Oncology Institute (TOIIW) EBT Margin (2021 - 2026)

Oncology Institute (TOIIW) has reported EBT Margin for 6 consecutive years, with 1.69% the latest figure, recorded in Q1 2026.

• EBT Margin for Q1 2026 came in at 1.69%, up 1707.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 8.0% (up 797.0% YoY), and the FY2025 annual result was 12.08%, up 435.0% from the prior year.
• EBT Margin was 1.69% for Q1 2026 at Oncology Institute, up from 5.29% in the prior quarter.
• Over five years, EBT Margin peaked at 35.29% in Q1 2022 and troughed at 39.31% in Q1 2023.
• Average EBT Margin over 5 years is 12.67%, with a median of 15.7% recorded in 2024.
• Year-over-year, EBT Margin jumped 3689 bps in 2022 and sank 7460 bps in 2023.
• Over 5 years, EBT Margin stood at 15.92% in 2022, then sank by 40 bps to 22.23% in 2023, then surged by 41 bps to 13.15% in 2024, then surged by 60 bps to 5.29% in 2025, then soared by 68 bps to 1.69% in 2026.
• Per Business Quant data, the three most recent EBT Margin figures were 1.69% in Q1 2026, 5.29% in Q4 2025, and 12.09% in Q3 2025.